Skip to content
healthcare.dev

Budesonide Inhalation Suspension

NDC 69097-321, Budesonide, inhalant, from Cipla USA Inc..

Product NDC
69097-321
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
INHALANT
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205710
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-321 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUDESONIDE1 mg/2mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
69097-321-536909703215330 POUCH in 1 CARTON (69097-321-53) / 1 AMPULE in 1 POUCH (69097-321-32) / 2 mL in 1 AMPULE
69097-321-87690970321876 POUCH in 1 CARTON (69097-321-87) / 5 AMPULE in 1 POUCH (69097-321-86) / 2 mL in 1 AMPULE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c52c5382-1400-44b9-95be-a30e1cf706da
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69097-321
  • NADAC price for package 69097032153

    GET /v1/drugs/nadac/69097032153
  • NADAC price for package 69097032187

    GET /v1/drugs/nadac/69097032187

Use it

Look up 69097-321 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-321 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-321. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.